I am an Associate Professor of Medicine and of Pathology & Immunology at Washington University School of Medicine in St. Louis, where I serve as Founding Director of the WashU Lupus Center and Director of the Biobanking and Phenotyping Core within the NIH/NIAMS-funded Washington University Rheumatic Diseases Research Resource-based Center. My translational research program centers on systemic lupus erythematosus, with major foci in complement activation product biomarkers and biology, sleep and circadian biology in autoimmune disease, health equity and social determinants of health, and COVID-19 vaccine immunogenicity in immunocompromised patients, the last of which generated a landmark publication in the Annals of Internal Medicine and wide national media attention during the pandemic. I am currently principal investigator on several federally-funded grants (NIH/NIAID, NEI, DoD) and multiple active CAR-T cell therapy trials in SLE. I hold an h-index of 35 across 96 publications and more than 7,000 citations. Beyond the laboratory and clinic, I serve on the Board of Directors of the Rheumatology Research Foundation — including as Chair of the Impact Advisory Council — and hold multiple leadership roles at the Lupus Research Alliance, including co-chair of the Biomarker Roadmap Committee and membership on the Cell Therapy Advisory Group. I am an active member of the OMERACT SLE Working Group and the Lupus Clinical Investigators Network, serve as Associate Program Director of the WashU Rheumatology Fellowship, and hold the role of Chief Medical Officer at Kypha, Inc., an innate immune diagnostics company grounded in my complement biology research.
Associate Professor
Medical School
1997 – 2005
Residency
2005 – 2007
Fellowship
2007 – 2011